CXCL8 and COVID-19: Plasma gelsolin is particularly effective towards S1-induced IL-8 and TNF-α secretion, both cytokines with a potent ability to impair endothelial permeability that has been widely associated with poor clinical outcomes for patients with COVID-19 [56, 57].